BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 8096749)

  • 1. Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.
    Graham-Pole J; Ayass M; Cassano W; Dickson N; Enneking W; Heare M; Heare T; Marcus R; Saleh R; Spanier S
    Cancer Treat Res; 1993; 62():339-46. PubMed ID: 8096749
    [No Abstract]   [Full Text] [Related]  

  • 2. An update of Scandinavian studies of osteosarcoma.
    Elomaa I
    Cancer Treat Res; 1993; 62():293-8. PubMed ID: 8096745
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience of the EORTC Radiotherapy/Chemotherapy Group in osteosarcoma trials.
    Burgers JM
    Cancer Treat Res; 1993; 62():173-5. PubMed ID: 8096730
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteosarcoma of the limb: an institutional report of 10 years experience with neoadjuvant chemotherapy and delayed surgery.
    Postma A; Kamps WA; Schraffordt Koops H; Veth RP; Göeken LN; Molenaar WM
    Cancer Treat Res; 1993; 62():361-4. PubMed ID: 7682095
    [No Abstract]   [Full Text] [Related]  

  • 5. The multi-institutional osteosarcoma study: an update.
    Link MP
    Cancer Treat Res; 1993; 62():261-7. PubMed ID: 7682087
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.
    Bacci G; Picci P; Ferrari S; Avella M; Prever BA; Ruggieri P; Casadei R; Lari S; Monti C; Cazzola A
    Cancer Treat Res; 1993; 62():299-308. PubMed ID: 7682090
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteosarcoma studies at St. Jude Children's Research Hospital from 1968 through 1990.
    Pratt CB; Meyer WH; Rao BN; Parham DM; Fleming ID
    Cancer Treat Res; 1993; 62():323-6. PubMed ID: 8096746
    [No Abstract]   [Full Text] [Related]  

  • 8. Osteosarcoma in adolescents and young adults: new developments and controversies. The Mayo Clinic studies.
    Miser JS; Pritchard DJ; Rock MG; Shives TC; Gilchrist GS; Smithson WA; Arndt CA; Edmonson JH; Schaid DJ
    Cancer Treat Res; 1993; 62():333-8. PubMed ID: 8096748
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteosarcoma: experience with the Rosen T10 protocol at RCH, Melbourne.
    Ekert H; Tiedemann K
    Cancer Treat Res; 1993; 62():355-9. PubMed ID: 7682094
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
    Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
    Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthermic isolated perfusion using cisplatin for treatment of the extremities.
    Takeyama S; Tateishi A; Higaki S; Yamanashi M
    Cancer Treat Res; 1993; 62():235-40. PubMed ID: 8096738
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
    Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
    Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering.
    Meyers PA; Heller G; Vlamis V
    Cancer Treat Res; 1993; 62():309-22. PubMed ID: 7682091
    [No Abstract]   [Full Text] [Related]  

  • 14. Update of osteosarcoma in Ramathibodi, Thailand.
    Sirikulchayanonta V; Pochanugool L; Subhadrabandhu T
    Cancer Treat Res; 1993; 62():371-4. PubMed ID: 8096752
    [No Abstract]   [Full Text] [Related]  

  • 15. The European Osteosarcoma Intergroup (E.O.I.) studies 1980-1991.
    Craft AW; Burgers JM
    Cancer Treat Res; 1993; 62():279-86. PubMed ID: 8096743
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoadjuvant high-dose methotrexate, cisplatin, and doxorubicin for the management of patients with nonmetastatic osteosarcoma.
    Weiner MA; Harris MB; Lewis M; Jones R; Sherry H; Feurer EJ; Johnson J; Lahman E
    Cancer Treat Rep; 1986 Dec; 70(12):1431-2. PubMed ID: 3466693
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
    Winkler K; Bielack SS; Delling G; Jürgens H; Kotz R; Salzer-Kuntschik M
    Cancer Treat Res; 1993; 62():269-77. PubMed ID: 7682088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma.
    Cassano WF; Graham-Pole J; Dickson N
    Cancer; 1991 Nov; 68(9):1899-902. PubMed ID: 1913541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Musculoskeletal tumour disorders.
    Marcove RC
    Compr Ther; 1996 Jan; 22(1):7. PubMed ID: 8654026
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination of gemcitabine and irinotecan for recurrent metastatic osteogenic sarcoma.
    Zak D; Styler MJ; Rosenbluth JZ; Brodsky I
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):297-9; discussion 300-2. PubMed ID: 16167002
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.